BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28153507)

  • 1. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
    Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
    Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
    Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL; Dao LN; McPhail ED; Jaffe ES; Said J; Swerdlow SH; Sattler CA; Ketterling RP; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Gibson SE; Ondrejka SL; Nicolae A; Macon WR; Dasari S; Parrilla Castellar E; Feldman AL
    Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal rearrangements and copy number abnormalities of TP63 correlate with p63 protein expression in lung adenocarcinoma.
    Aubry MC; Roden A; Murphy SJ; Vasmatzis G; Johnson SH; Harris FR; Halling G; Knudson RA; Ketterling RP; Feldman AL
    Mod Pathol; 2015 Mar; 28(3):359-66. PubMed ID: 25189640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma.
    Feldman AL; Oishi N; Ketterling RP; Ansell SM; Shi M; Dasari S
    Am J Surg Pathol; 2022 Nov; 46(11):1490-1499. PubMed ID: 35941721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C; Chen X; Chen XY; He YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.
    Peterson JF; Pearce KE; Meyer RG; Greipp PT; Knudson RA; Baughn LB; Ketterling RP; Feldman AL
    Histopathology; 2020 Feb; 76(3):481-485. PubMed ID: 31557339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
    Xing X; Flotte TJ; Law ME; Blahnik AJ; Chng WJ; Huang G; Knudson RA; Ketterling RP; Porcher JC; Ansell SM; Sidhu J; Dogan A; Feldman AL
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):580-9. PubMed ID: 25390351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.
    Parkhi M; Bal A; Das A; Kashyap D; Bhardwaj S; Prakash G; Malhotra P
    Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):648-656. PubMed ID: 33901030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
    Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
    Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
    Irshaid L; Xu ML
    Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
    Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
    Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas.
    Yu R; Chen G; Zhou C; Gao Z; Shi Y; Shi Y; Zhou X; Xie J; Liu H; Gong L
    Leuk Res; 2012 Sep; 36(9):1141-6. PubMed ID: 22726922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic large cell lymphoma with TP63 rearrangement: A dismal prognosis.
    Yamashita T; Higashi M; Kawano R; Momose S; Tokuhira M; Kizaki M; Tamaru JI
    Pathol Int; 2019 Mar; 69(3):155-159. PubMed ID: 30719810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of anaplastic large cell lymphoma.
    Zeng Y; Feldman AL
    Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
    Fadl A; Oishi N; Shi M; Dasari S; Ansell SM; Ketterling RP; Feldman AL
    Hum Pathol; 2023 Nov; 141():6-14. PubMed ID: 37633531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with
    Luchtel RA; Dasari S; Oishi N; Pedersen MB; Hu G; Rech KL; Ketterling RP; Sidhu J; Wang X; Katoh R; Dogan A; Kip NS; Cunningham JM; Sun Z; Baheti S; Porcher JC; Said JW; Jiang L; Hamilton-Dutoit SJ; Møller MB; Nørgaard P; Bennani NN; Chng WJ; Huang G; Link BK; Facchetti F; Cerhan JR; d'Amore F; Ansell SM; Feldman AL
    Blood; 2018 Sep; 132(13):1386-1398. PubMed ID: 30093402
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Ketterling RP; Bedroske PP; Luoma IM; Sattler CA; Boddicker RL; Bennani NN; Nørgaard P; Møller MB; Steiniche T; d'Amore F; Feldman AL
    Blood; 2017 Jul; 130(4):554-557. PubMed ID: 28522440
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior.
    Gerbe A; Alame M; Dereure O; Gonzalez S; Durand L; Tempier A; De Oliveira L; Tourneret A; Costes-Martineau V; Cacheux V; Szablewski V
    Virchows Arch; 2019 Aug; 475(2):163-174. PubMed ID: 30953147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
    Xing X; Feldman AL
    Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.